We recently showed that the 52,000-dalton external glycoprotein (gp52) of the highly oncogenic mouse mammary tumor viruses (MMTVs) of RUI, GR, and C3H mice contains both type-and group-specific antigenic determinants. This was demonstrated by using a competition radioimmunoassay with '"I-externally labeled virions and antisera to the gp52 of MMTV from RIH mice (Proc. Natl. Acad. Sci. U.S.A. 74:3564-3568, 1977). We report here that we were able to distinguish between the gp52's of the high-oncogenic MMTV of C3H mice [MMTV(C3H)] and the low-oncogenic MMTV of that same mouse strain [MMTV(C3Hf)]. This was accomplished by use of a competition radioimmunoassay with l"I-externally labeled virions of MMTV(C3H) and antisera prepared against MMTV(C3H). A comparison of the intact virion and purified gp52 radioimmunoassays showed that MMTV type-specific differences were enhanced with the intact vision radioimmunoassay. These differences were further magnified with appropriately absorbed antisera. These findings thus allow an immunological distinction between the surface glycoproteins of a low-oncogenic endogenous and a high-oncogenic exogenous MMTV of the same mouse strain.
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Various strains ofmice differ in their incidence of mammary tumors, latent period to tumor formation, and type of tumor formed. To assess the role of a viral involvement in these parameters, it is important to distinguish between virusdirected and host-controlled activities. A central issue is the determination of the number of mammary tumor viruses that exist in different strains of mice or even within a given mouse.
Previous reports (1, 23, 24) have indicated some differences in biological activities of different mouse mammary tumor virus (MMTV) isolates. Recent studies have further shown that some MMTVs may differ substantially both in the sequences of their RNA genomes and in the mechanism by which they are transmitted (7, 9, 22) .
Immunological studies of MMTVs, using the technique of immunodiffusion, with viruses derived from mouse milk presented evidence that different MMTV preparations share some antigens and not others (2) . Some of these studies are difficult to interpret, however, due to the lack of quantitation by the immunodiffusion technique and the unavailability of purified viral reagents at the time the studies were performed. Studies with the sensitive competition radioimmunoassay technique, however, have not detected any differences among various MMTVs; i.e., only group-specific reactivities have been reported (5, 18, 25, 27, 30, 32, 36) .reactivity with a particular MMTV and no reactivity with others. Evidence is also presented to show that type-specific differences among MMTVs are best observed by using externally labeled virion assays as opposed to assays with purified "2I-labeled gp52's.
MATERIALS AND METHODS
Viruses. MMTVs were obtained from the milk of RIII and C3HfC57BL mice (11, 24) and from culture fluids of primary RiII mammary tumor cells (18) and Mm5mt/c, C3H (26) and GR (29) mammary tumor cell lines. MMTVs were also obtained from culture fluids of feline CrFK cells infected with MMTV from RIII and GR milk or infected with concentrated supernatant fluids from the C3H mammary tumor cell line Mm5mt/c, (12, 19) . MMTVs from RIII, C3H, C3HfC57BL, and GR mice are designated MMTV(RIII), MMTV(C3H), MMTV(C3Hf), and MMTV(GR), respectively. The C3HfC57BL strain was originated (11, 24) 3 ,000 x g for 10 min, KCl was added to 0.8 M, and the extracts were sonically treated (Branson Sonifier, setting 7) for 2 min at 10-s intervals on ice. The extracts were further clarified at 10,000 x g, and the supernatant fluid was dialyzed overnight against TNE and stored at -70'C until used. C57BL/6 milk was mixed with an equal volume of 0.15 M EDTA (pH 7.8) and centrifuged at 10,000 x g for 10 min. The layer between the casein pellet and lipid was removed and dialyzed. All proteins were determined by the method of Lowry et al. (20) .
Purification of viruses. MMTV from mouse milk was mixed with an equal volume of 0.15 M EDTA (pH 7.8) and centrifuged at 10,000 x g for 10 min. The clarified milk between the lipid and precipitated casein was layered onto an 8-ml cushion of 25% glycerol and centrifuged at 95,000 x g for 60 min in an SW27 rotor (Beckman). The resulting pellet was layered onto a 15 to 65% (wt/vol) sucrose gradient and centrifuged at 95,000 Xg for 3 h. Fractions were collected by bottom puncture, and the material absorbing at 260 nm between 1.15 and 1.19 g/ml was pooled, diluted with TNE, and centrifuged at 95,000 x g for 1 h. The pellet was then resuspended in TNE to a concentration of 1 J. VIROL. mg/ml and stored at -700C. MMTV was also obtained from cell culture fluids by use of previously described procedures (35) . Briefly, culture fluids were clarified of cellular debris, and virus was concentrated by ammonium sulfate precipitation. The concentrated virus was then purified by using a series of discontinuous and linear sucrose gradients. MMTV preparations from murine or feline sources used in these studies were found to be negative for type C retroviruses as determined by electron microscopy, reverse transcriptase assays, gel protein profiles, radioimmunoassays (kindly performed by C. Sherr and G. Todaro), immunodiffusion analyses, and nucleic acid hybridization, as described previously (12, 17, 18, 31) .
Purification of MMTV gp52. The 52,000-dalton glycoprotein of MMTV (gp52) was purified by using the procedure described by Ritzi et Radioimmunoassay. Radioimmunoassays for externally iodinated MMTV virions were carried out as described by Cardiff (5) with minor modifications. All dilutions were made in borate saline buffer (5 g of Na2B407 1OH20-7 g of H3BO3,7.8 g of NaCl, in 1,000 ml, pH adjusted to 7.4 with HCl) containing 0.2% bovine serum albumin. Competing antigens in 100 ILI were added to 10 p1 of appropriately diluted antisera and incubated at 37°C for 1 h. Iodinated antigen (10,000 cpm) in 40 pI was then added, followed by incubation at 37°C for 1 h. Finally, 50 p1 of either goat anti-rabbit or porcine anti-goat immunoglobulin G was added, and the incubation was continued for an additional hour at 37°C and then kept overnight at 4°C. After centrifugation at 10,000 x g for 1.5 min, 100 pI of the supernatant was removed and counted.
The remaining 100 ,l of the total sample was also counted. Percent precipitation was calculated by dividing the difference in counts per minute between the two 100-1l portions by the sum in counts per minute of the same portions and multiplying by 100. Percent bound was calculated by dividing percent precipitation in the presence of competing antigen by the percent precipitation in the absence of competing antigen and multiplying by 100. Nonspecific binding, i.e., binding in the absence of immune sera (0 to 5%), was subtracted from all percent precipitations.
Radioimmunoassays for purified gp52 were performed as described above, with the exception that the incubation time after the addition of labeled antigen was increased to 2 h at 37°C. The antisera dilutions given are those used before addition to reaction mixtures, unless otherwise specified.
RESULTS
Characterization of reagents. Radioimmunoassays for intact MMTV visions and purified MMTV gp52's were used in these studies. After labeling of intact MMTVs with lactoperoxidase, virions were rebanded in sucrose gradients and displayed a discrete peak at a buoyant density of 1.17 g/cm3. The electrophoretic patterns in sodium dodecyl sulfate-polyacrylamide gels of MMTV(C3H) virions iodinated without disruption showed that >90% of the 12"I label migrated as a 52,000-dalton species. Similarly, electrophoretic patterns of purified "261-labeled gp52's of MMTV(C3H) or unlabeled MMTV(C3H) gp52 stained with Coomassie brilliant blue revealed the presence of a single homogeneous component migrating as a 52,000-dalton molecule. Patterns very similar to those obtained with MMTV(C3H) have been reported elsewhere for MMTV(RIII) (34) .
Titration curves of the binding of antisera prepared against MMTV(C3H) to "261-labeled MMTV(C3H) and MMTV(RIII) virions or 5I-labeled gp52's of those viruses are shown in Fig.  1A and B, respectively. Eighty percent or greater of labeled virions or gp52's were precipitated by the antisera. The differences in titer seen in this experiment with labeled virions may reflect differences in either degree of purity or specific activity of the preparations, since purified gp52 preparations from MMTV(RIII) and MMTV(C3H) gave similar (Fig. 1B) (Fig. 2A) . These same non-MMTV antigens likewise did not compete in any of the other MMTV radioimmunoassays described below. Type-and group-specific reactivities. The ability of antisera prepared against MMTV(C3H) to precipitate 125I-labeled MMTV(C3H) was completely inhibited by the addition of 5 jg of unlabeled MMTV(C3H) (Fig.  2A) . The addition of as much as 100 jg of unlabeled MMTV(RIII), however, caused only 75% inhibition ( Fig. 2A) . The competition curve generated by increasing quantities of MMTV(RIII) also displayed a much shallower slope ( Fig. 2A) than the curve generated by the addition of MMTV(C3H). The altered reactivity of MMTV(RIII) was not due to incomplete purification or antigenic damage of MMTV(RIII), since both MMTV(RIII) and MMTV(C3H) competed identically in terms of both quantity and slope when used as inhibitors in an assay employing the same anti-MMTV(C3H) sera and "2I-labeled MMTV(RIII) (Fig. 2B ). It appears, therefore, that in addition to indistinguishable, i.e., group-specific, antigenic determinants (18, 25, 27, 32, 36) (Fig. 2B) , MMTV(C3H) and MMTV(RIII) also appear to contain related, but clearly distinguishable type-specific, surface antigenic determinants.
The possibility existed that the type-specific differences observed between these two MMTVs were due to differences in host-coded glycosylation or in antigens on the surface of the mouse cells producing the viruses. To exclude these possibilities, both MMTV(C3H) and MMTV(RIII) were grown in the same CrFK feline cell line. MMTV(C3H) and MMTV(RIII) grown in feline cells continued to ethibit the same type-specific differences as their counterparts grown in murine cells when assayed in the anti-MMTV(C3H) versus 1"I-labeled MMTV(C3H) assay. Both feline-grown viruses, moreover, competed identically in the anti-MMTV(C3H) versus "MI-labeled MMTV(RIII) group-specific assay. The maintenance of both the group-and type-specific determinants in these two MMTVs grown in the same feline cells is strong evidence that these antigenic reactivities are virus coded and are not due to differences in host-coded glycosylation or in murine antigens from different strains of mice.
Comparable results were obtained when the reciprocal assays were conducted with antisera to MMTV(RIII) instead of antisera to MMTV(C3H). MMTV(RIII) competed in the anti-MMTV(RIII) versus "251-labeled MMTV(RIII) assay with a steeper slope than did MMTV(C3H). This same relationship was maintained when these MMTVs were grown in feline cells and used as competitors. Both of the murine-and feline-grown MMTVs were indistinguishable from each other, however, in an assay with the same anti-MMTV(RIII) sera and 15I-MMTV(C3H) as the labeled antigen (34 peted in the virion assays in a manner similar to the virion preparations from which they were derived. These studies have been described in detail previously (34) . To further characterize the group-and type-specific reactions observed, the antigenic reactivities of gp52's of MMTVs were studied in assays with "SI-labeled purified gp52's. Competition radioimmunoassays with iodinated gp52's from MMTVs of C3H and RH mice were employed as described in Materials and Methods. Unlabeled purified gp52 preparations were used as competitors.
In the assay with antisera to MMTV(C3H) and III-labeled gp52 of MMTV(C3H), unlabeled gp52 of MMTV(RIII) competed with a shallower slope and required greater protein inputs for similar levels of blocking when compared with unlabeled gp52 of MMTV(C3H) (Fig. 3A) .
In the assay with the same anti-MMTV(C3H) sera but "2I-labeled gp52 of MMTV(RIII), however, unlabeled gp52's of both MMTV(C3H) and MMTV(RIII) competed identically (Fig. 3C ). In the reciprocal experiments, purified gp52 of MMTV(RIII) competed with a steeper slope and with less protein input for comparable blocking than purified gp52 of MMTV(C3H) in an assay with anti-MMTV(RIII) serum and '"Ilabeled gp52 of MMTV(RIII) (Fig. 3B) . Finally, in an assay with this same anti-MMTV(RIII) sera and III-labeled gp52 of MMTV(C3H), unlabeled gp52's of both MMTV(C3H) and MMTV(RIII) competed similarly (Fig. 3D ).
These data demonstrate that type-and groupspecific reactivities consistent with those observed in assays with externally iodinated virions are seen in assays with purified gp52 preparations.
Effect of antisera dilution. The resolution of the type-specific reactivities observed between MMTV(C3H) and MMTV(RIII) was found to be affected by the dilution of antisera used in the assay. In the assay with antisera prepared against MMTV(C3H) and "2I-labeled MMTV(C3H), antigenic differences between MMTV(C3H) and MMTV(RIII) were readily detected at low-input dilutions of antisera (1:5,000) (Fig. 4A) . As the dilution of antisera used in the assay was increased, the differences observed were reduced ( Fig. 4B and C) . At highinput antibody dilution (1:500,000), no difference between the reactivities of MMTV(C3H) or MMTV(RIII) was observed (Fig. 4D) . It is important to note that the antisera dilutions used (1:5,000 to 1:500,000) were all in the range of limiting antibody (see Fig. 1A ). The reduction in detectable antigenic differences between the two viruses as the antibody dilution was increased may reflect a limited titer of higheraffinity antibodies directed against type-specific determinants. On the other hand, antibodies directed against the group-specific determinants appeared to be present in higher titer. Reciprocal experiments with an assay with antisera to MMTV(RIII) and "MI-labeled MMTV(RIII) gave analogous results.
Radioimmunoassays with the low antibody dilutions retained specificity for MMTV antigens. The type C retroviruses and cell extracts listed in the legend to Fig. 2 still did not compete in these assays.
Low-oncogenic MMTV(C3Hf). Purified MMTV(C3H) and MMTV(C3Hf) virions were used as competitors in the assay with antisera to MMTV(C3H) and 1MI-labeled MMTV(C3H).
Greater than 100 times more MMTV(C3Hf) than MMTV(C3H) was required as competitor to achieve 50% competition (Fig. 5A) . The slope of competition curves generated by increasing amounts of MMTV(C3Hf) was also shallower than that of MMTV(C3H). In an assay with antisera to MMTV(RIII) and "MI-labeled VOL 24, 1977 on October MMTV(C3H), however, both MMTV(C3H) and MMTV(C3Hf) competed completely and with comparable slopes (Fig. 5B) , demonstrating the group-specific reactivities of these two C3H viruses and contrasting with the type-specific reactivities seen in Fig. 5A . The results of Fig. 5B further rule out the possibilities that the differences observed in Fig. 5A were a function of the physical state of the virions employed or differences in virus titers.
Tumors that occur late in the lives of C3HfC57BL mice (1, 11, 24) and contain MMTV(C3Hf) could also be immunologically distinguished from early mammary tumors of C3H mice. As seen in Fig. 6 group-specific assay with antisera to MMTV(C3H) and "WI-labeled MMTV(RIII).
Only partial blocking, with an altered slope, however, is observed when the extract is added to the type-specific assay with antisera to MMTV(C3H) and 125I-labeled MMTV(C3H). Absorption of antisera. The incomplete competition with MMTV(C3Hf) in the anti-MMTV(C3H) versus 1"I-labeled MMTV(C3H) assay suggested the possibility of eliminating group-specific reactivity by absorption while retaining or enhancing type-specific reactivities. The antisera to MMTV(C3H) was preincubated with purified MMTV(RIII) as described in the legend to Fig. 7 , and the resulting serum was used in competition assays with 1"I-labeled MMTV(C3H). Unlabeled MMTV(RIII) no longer competed for the binding of the 1"I-labeled MMTV(C3H) (Fig. 7A) . Moreover, addition of high levels of MMTV(GR) now resulted in little, if any, competition (Fig. 7A) . Addition of MMTV(C3H) and MMTV(C3Hf), however, caused inhibition with similar differential effects, as described earlier.
A striking magnification of type-specific reactivities is seen in Fig. 7B . Antisera to MMTV(RIII) was preincubated with MMTV(C3H), and the resulting sera was used in an assay to bind "2I-labeled MMTV(RIII). Whereas MMTV(RIH) competed completely in this assay, the addition of similar quantities of MMTV(C3H), MMTV(C3HfO, or MMTV(GR) gave no competition.
To exclude the possibility that the absorption procedures merely removed all MMTV-specific reactivities and accentuated lesser reactivities due to type C viruses or other contaminants, the specificity of the absorbed antiserum was further examined. The binding of the absorbed antisera to III-labeled MMTVs could not be inhibited by the addition of type C virus, normal mouse tissues, mouse milk, or fetal calf serum proteins. In addition, the binding of the antisera prepared against MMTV(C3H), which had been absorbed with MMTV(RIII), to '25I-labeled MMTV(C3H) could be completely inhibited by the addition ofpurified gp52 from MMTV(C3H), indicating further that the observed type-specific reactivities were due to antigens present on the MMTV gp52 molecule and not to reactivities of other MMTV polypeptides. DISCUSSION The studies reported here demonstrate that, in addition to the group-specific reactivity previously reported (18, 25, 27, 36) , the major external glycoprotein (gp52) of MMTVs also contains type-specific antigenic determinants. The viruscoded nature of both the group-and type-specific determinants is made evident by the fact that MMTVs grown in the same feline cell line (12) retain the reactivities they displayed when grown in murine cells. It is therefore highly improbable that the type-specific differences observed are due to either differences in host-derived antigens (murine or feline) or differences in host-coded glycosylation.
The type-specific reactivities observed could be magnified by any one of three procedures: (i) the use of an antisera dilution that is limiting but does not give maximum sensitivity; (ii) the use of the virion assay instead of the purified gp52 assay; and (iii) the absorption of antisera with a particular strain of MMTV.
It is well documented that titer and affinity are two independent properties of a given antisera (8, 13) . As shown in Fig. 4 , the population of antibodies that distinguishes the MMTV of C3H from that of RHI mice is present at lower titer but appears to have a higher affinity for gp52 determinants. This population of antibodies can be completely eliminated by dilution of the antisera (Fig. 4D) . This may be a general feature of antibodies raised against MMTV gp52's, since the three different antisera used (see Materials and Methods) all displayed this same property. Since most investigators set up their assays to obtain maximum sensitivity by using extremely high antisera dilutions, it is not surprising that the MMTV type-specific determinants have been previously overlooked.
It also appears that the use of virion assays demonstrates the type-specific reactivities of MMTVs to a greater extent than do the assays with purified gp52's. The results shown in Fig.  3 , with purified gp52 assays, are consistent with those of Fig. 2 , with virion assays, but typespecific differences are magnified in the latter. It is possible that the radiolabeled virion reflects a more native configuration of the gp52 molecule, and that iodination of the purified gp52 molecule further alters its immunological reactivity. A previous study (27) has presented convincing evidence, moreover, that the purified gp52 molecule shows marked differences in its "native" versus "denatured" state. Indeed, measurement of gp52 in whole virus, tissues, or milk in that study (27) did not give complete displacement curves. The virion assays used here for MMTV are specific for gp52, as shown by the fact that purified gp52 of MMTV, when added as competitor, completely inhibits the vision assay in the same manner as unlabeled virus (34) .
The presence of both type-and group-specific determinants on the major external glycoprotein of the MMTV type B virion is analogous to previous findings of both type-and group-specific reactivities of the gp7O molecule of type C viruses (3, 33) . These latter studies have led to better definitions of the host's immune response to virus-induced leukemia (14) (15) (16) . The distinction that can now be drawn between group-and type-specific determinants on the surface of MMTVs may now lead to similar studies involving mammary tumorigenesis. Furthermore, the antigenic distinction that can now be drawn between the non-germ line-transmitted MMTV and the endogenous MMTV of a given animal may make possible a better understanding of the mechanism of viral-chemical and viral-hormonal interactions in the etiology of mammary cancer.
